A year ago, North America and Europe accounted for 40% of what APR Co., Ltd. (KRX:278470) sold. In the second quarter of 2026 they accounted for 68%. Overseas revenue as a whole reached more than ₩700bn, up 178% year on year, and represented 92% of the group's ₩767.5bn total.
Eight cents of every won APR now earns comes from Korea.
That is a faster geographic re-basing than most companies manage in a decade, and it changes what the stock is. A Korean beauty company selling to Koreans and exporting opportunistically is one kind of asset. A company whose demand, pricing, logistics and regulatory exposure sit almost entirely in the United States and Europe, while its cost base and listing sit in Korea, is another.
The numbers underneath are worth laying out. First-quarter 2026 US sales alone were ₩248.5bn, up more than 250% year on year and more than 40% of the group total in that quarter. The cosmetics and beauty division grew 185.5% to ₩648.3bn in the second quarter, about 85% of everything the company sold.
For scale: APR's entire FY2024 revenue was ₩722.8bn. The company now does more than that in a single quarter, and it does most of it in currencies that are not the won.
The obvious question is durability. K-beauty has had a US moment before — Amorepacific and LG Household & Health Care both built and then lost significant overseas positions — and the pattern in that industry is that a brand catches an algorithm or a retailer's attention, compounds violently for two or three years, and then plateaus when the novelty passes and the shelf space gets shared with the next thing.
What is different here, potentially, is the device. APR's original proposition was a home skincare appliance under the AGE-R brand that creates a reason to keep buying the associated creams. If that works, the customer relationship outlasts the trend. Whether it is working is not something the summary financials answer. The reporting groups cosmetics and beauty together, which leaves roughly ₩119bn of second-quarter revenue in everything else, and I cannot tell from the outside how much of the ₩648.3bn is device and how much is cream. Anyone underwriting the razor-and-blades thesis should go to the segment note.
The economics are unusual enough to spell out. Gross margin was 79.2% in the second quarter — ₩607.8bn of gross profit on ₩767.5bn of revenue. That is a software-like figure for a company shipping physical jars and handheld appliances across an ocean.
But operating margin was 24.8%. The ₩417.2bn between those two lines, roughly 54% of revenue, is what APR spends on everything else: advertising, influencer and creator programmes, marketplace fees, logistics, platform commissions and staff.
That ratio is the business. APR is not a company with a cost advantage in manufacturing. It is a company that has figured out how to acquire customers profitably at very high volume, and the enormous gross margin exists to fund that acquisition. The encouraging trend is that the ratio has been improving: operating expenses ran 63.4% of revenue in FY2022, 58.2% in FY2024 and 52.7% in FY2025. The second quarter of 2026 ticked back up to 54.4%.
That tick matters more than it looks. If customer acquisition cost is rising as the company scales into more competitive Western channels, the operating margin compresses even while revenue doubles, because the gross margin has no more room to give.
Ninety-two percent of revenue in foreign currency, with a manufacturing and headcount base in Korea, means APR has been running a large unhedged tailwind. A weaker won inflates reported revenue and expands margin simultaneously, because the receipts translate up and the costs do not.
That tailwind may be turning. The Bank of Korea raised its base rate to 3.00% on 27 August 2026, its second consecutive increase, alongside a growth forecast lifted to 3.3%. Rate rises and stronger growth do not always strengthen a currency, and I am not forecasting the won. But an investor extrapolating 134% revenue growth should know that some unknowable portion of it is translation rather than volume, and that the same mechanism runs in reverse.
The filings I read do not quantify APR's FX hedging or its constant-currency growth. Neither figure appears in the summary statements. Both are standard disclosures for a US-listed consumer company with this profile, and their absence is a gap.
There is a related exposure the company has not sized publicly either. A business shipping physical goods from Korea into the United States carries trade-policy risk on the landed cost of every unit, and nothing in the half-year report I read puts a number on it. With 68% of revenue now in North America and Europe, that is no longer a rounding error.
The bull argument is straightforward and I think largely right. The addressable market for skincare in the United States is many times Korea's, the pricing is better, and a Korean brand with genuine product differentiation has never had an easier route in — direct online channels and marketplaces have removed the retailer gatekeeper that stopped previous generations of K-beauty from scaling.
Diversification, in that framing, would be a failure. A company with a working formula in the largest and most profitable market should put everything behind it, and the 40%-to-68% shift is management executing rather than drifting. Fidelity Management and Research has filed substantial shareholding reports twice in three months, which is at least a signal that serious foreign money has looked at the same numbers.
And the operating leverage is real. Growing revenue 134% while holding a 24.8% operating margin means the fixed costs of the platform are being spread, not consumed.
The regional split in the third quarter. Two things to look for: whether North America and Europe hold above two-thirds of revenue, and whether the growth rate inside those regions is decelerating. A slowdown from 250% to 120% would still be extraordinary and would still mark the top of the curve.
Second, the operating expense ratio. It went 58.2%, then 52.7%, then back to 54.4%. If the third quarter runs above 55% while revenue growth slows, then acquisition costs are rising faster than scale benefits and the margin story ends before the revenue story does.
Third, any disclosure at all on constant-currency growth or hedging. A company earning 92% of its revenue abroad should be telling shareholders how much of its growth is real. Until it does, some portion of the multiple is being paid for the exchange rate.
kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.